Dyne Therapeutics Inc (DYN)

14.33 -0.04  -0.28% NASDAQ Oct 22, 16:00 14.26 -0.07  -0.49% After-Hours: 20:00 USD

Dyne Therapeutics Cash from Operations (TTM):

-96.46M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -96.46M
March 31, 2021 -57.61M
Dec. 31, 2020 -46.51M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

Veracyte Inc -34.66M
Moderna Inc 9.191B
BridgeBio Pharma Inc -470.42M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -96.46M Jun 2021
Maximum -46.51M Dec 2020
Average -66.86M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.